Family Medicine Doctors in Augusta, KS Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Michele A Ridder, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 1306 State St, Augusta, KS 67010 Phone: 316-775-9191 Fax: 316-775-0348 |
 Dr. Scott N Harder, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2820 Ohio St, Augusta, KS 67010 Phone: 316-775-7500 Fax: 316-775-3685 |
News Archive
Leaf-shaped prototype reactor could act as 'mini-factory' for drugs
To produce drugs sustainably and cheaply, anywhere you want. Whether in the middle of the jungle or even on Mars. A 'mini-factory' whereby sunlight can be captured to make chemical products.
Researchers develop potent new drug that can kill tumor cells
All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments. Now, researchers at the Perelman School of Medicine; the Abramson Cancer Center; and the School of Arts and Sciences, at the University of Pennsylvania, have developed a potent new drug that clogs up the recycling machinery and kills tumor cells in mouse models.
Data from Alvine's ALV003 Phase 2A trial on celiac disease presented at DDW 2012
Alvine Pharmaceuticals, Inc. today announced the presentation of data from a Phase 2A trial of its lead compound, ALV003, at the 2012 Digestive Diseases Week (DDW) meeting held in San Diego, California. The study results met the primary endpoint of demonstrating that oral ALV003, administered in the context of a gluten free diet (GFD), can diminish gluten-induced intestinal mucosal injury in well-controlled celiac disease patients. The company plans to initiate a Phase 2B trial later this year.
COUP-TFII plays pivotal role in obesity, metabolic syndrome
A protein known to play a role in development and the formation of organs is also an important factor in the control of obesity and diabetes, said researchers from Baylor College of Medicine in a report that appears in the current issue of the journal Cell Metabolism.
VolitionRx selects Global Specimen Solutions to support U.S. market entry of NuQ colorectal cancer tests
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has engaged the services of a specialty specimen management clinical research organization, Global Specimen Solutions, Inc., to support initial U.S. market entry of its NuQ colorectal cancer tests.
› Verified 6 days ago